Petplan, the pet insurance provider has been selected as a Which? Best Buy. The independent consumer guide selected Petplan's 'Covered For Life' policy that covers animals for accidents and illnesses, including reoccurring conditions, such as diabetes and glaucoma, year after year, as long as the policy is renewed annually.
Alison Andrew, Petplan's Marketing Manager said: "The Which? report is crucial to being acknowledged as a worthy pet insurance provider. We feel being selected as a Which? Best Buy reflects how we treat our customers by offering excellent customer service, paying claims quickly, discounts on pet products and regular information about pet care through our magazine PetPeople."
Petplan provides insurance cover for dogs, cats, rabbits and horses and is the largest provider of animal health insurance in the world.
TR Biosurgical will be officially launching its new surgical treatment for canine glaucoma at the American College of Veterinary Ophthalmologists annual conference in Chicago at the start of November.
TR-ClarifEYE is an sub-scleral implant placed in the eye in a procedure that takes around 30 minutes.
TR Biosurgical CEO Craig Woods DVM said: "TR-ClarifEYE is made from new silicone substrate subjected to a unique process which reduces fibrosis and enhances healing."
"Until now, the primary treatment options for canine glaucoma have been laser surgery, cryosurgery, evisceration or enucleation. Certain procedures can be either complicated and expensive, or fail to save the eye. Previous implants have met with only limited success, and TR-ClarifEYE appears to overcome many of the problems with glaucoma implants."
"This new implant is a relatively easy surgical approach. It has limited post-op complications. It seems to provide long term glaucoma management in the majority of patients, most of which are able to reduce medications."
For more information about TR-ClarifEYE, visit: http://www.petglaucoma.com
Practitioners interested in learning more about this procedure, click here and 'start conversation' with Craig
The Disciplinary Committee of the RCVS has approved an application for restoration to the Register from an Oxfordshire veterinary surgeon who had been struck off for false certification.
In November 2007, the Committee decided that Mr John Williams, of the Avonvale Veterinary Practice in Ratley, near Banbury, should have his name removed from the RCVS Register, having found him guilty of disgraceful professional conduct. Mr Williams had admitted signing export health certificates for three horses in October 2006 to state that they had received negative test results for the contagious equine metritis organism, before these results were actually available.
At the time, Mr Williams was working in his capacity as an Official Veterinarian (OV) for DEFRA and he had previously been suspended from his official duties on three separate occasions, on the basis of export certification irregularities. It was accepted that Mr Williams had not been dishonest, but his approach to certification was described by the Disciplinary Committee as "either irresponsible or cavalier or both".
In December 2007, Mr Williams appealed against this decision to the Privy Council but this was dismissed at a Hearing the following June. He was then removed from the Register in July 2008.
When the Committee met on Monday to consider Mr Williams' application, they heard oral and written supporting evidence from veterinary surgeons and equine clients, and oral evidence from Mr Williams himself. The Committee was satisfied that Mr Williams accepted its previous findings and fully understood their seriousness. He described his removal from the Register as a "salutary experience" which had been highly significant for him and his family, both financially and emotionally.
The Committee stated: "Although the decision of the Committee to remove [Mr Williams] from the Register sent a clear message to the profession of the importance of certification, it should be emphasised that his removal was the consequence of his actions in signing certificates which he could not verify. This followed three previous occasions on which he had similarly signed certificates when he should not have done so."
However, the Committee was satisfied that Mr Williams would not in future sign certificates when he should not do so, even under severe client pressure. It was impressed with the continuing professional development he had undertaken whilst off the Register and noted that no questions had been raised over his conduct during this time.
It concluded that Mr Williams fully understood the importance of accurate certification and that restoring his name to the Register therefore posed no risk to animal welfare. Neither the public nor the profession would benefit from Mr Williams staying off the Register for a further period.
Alison Bruce, Disciplinary Committee Chairman, said: "We would like to make it clear that we always find it distressing to remove clinically competent veterinary surgeons from the Register because of an irresponsible and cavalier attitude towards certification. This would not be necessary if veterinary surgeons were to follow the Twelve Principles of Certification annexed to the RCVS Guide to Professional Conduct."
The Committee then approved Mr Williams' application and directed that his name should be restored to the Register.
SMALL ANIMAL MEDICINE SOCIETY Case Report Competition 2010
Sponsored by Vetoquinol
Do you have an interesting or unusual small animal medicine case that would be suitable to present as an oral abstract. The Small Animal Medicine Society is currently inviting submissions for the case report session during the pre BSAVA satellite meeting on April 7th 2010.
This Competition is open to anyone with an interest in canine or feline medicine. Suitable cases should be have interesting discussion points but need not be so unusual that they would be considered publishable.
Three case reports will be selected by the SAMSOC committee for presentation during the meeting (12 minutes plus 3 minute for questions).
Successful selection entitles the author to free registration for the meeting.
At the end of the session the audience will vote by ballot for their favourite case report. Each presenter will then be awarded a prize which has been kindly donated by Vetoquinol.
1st place £300,
2nd place £150
3rd place £50
If you are interested in submitting a case report please contact Stijn Neilson ( sniessen@RVC.AC.UK )or Sheena Warmen (Sheena.Warman@bristol.ac.uk) for details. Deadline for submission is February 1st 2010
The Blue Cross is to be the first animal charity to star in a BBC Lifeline appeal to help raise funds for animals in need.
Presented by actress Felicity Kendal and her cocker spaniel George, the short film shows the work of the charity which helps thousands of sick and homeless animals every year.
Felicity Kendal said: "I'm delighted to be able to help publicise the work of this wonderful charity. The Blue Cross does so much to help animals in need and they rely almost entirely on public donations. I hope lots of people watch the BBC appeal to see just where the money goes and why this is a charity worthy of their support."
The BBC Lifeline appeal featuring The Blue Cross will be broadcast on BBC2 on Wednesday 28th October at 2pm.
The film will also be available to view on the BBC website until the end of November at www.bbc.co.uk/lifeline. Thereafter it can be viewed on The Blue Cross website at http://www.bluecross.org.uk/.
kcs-intervet.swfIntervet / Schering-Plough Animal Health is running a challenge over the next few months to encourage the early diagnosis of Keratoconjunctivitis sicca (KCS), a painful disease which leads to permanent blindness (see right).
Practices are being asked to perform a Schirmer Tear Test (STT) on 50 dogs not previously diagnosed with KCS for the chance to win one of 70 Samsung digital cameras.
Recent studies¹ have shown the incidence of KCS to be 4.6% of the UK dog population, rising to 8.3% in predisposed breeds. However, 20 veterinary practices have recently participated in an Early Diagnosis Programme and the number confirmed with KCS was 9.7%². 17 of the cases diagnosed had Schirmer Tear Test readings of zero.
KCS is thought to be under-diagnosed because not all cases have the classic 'textbook' appearance but look surprisingly normal despite severely reduced tear production. In addition, diagnosis usually requires clinical suspicion and a Schirmer Tear Test.
Claudia Hartley, BVSc CertVOphthal DipECVO MRCVS, European Specialist in Veterinary Ophthalmology believes that: "All sore eyes (except where a descemetocoele is present) should have a Schirmer Tear Test, whether or not there is corneal change."
Melanie Dass MA VetMB CertSAM MRCVS ACIM, Product Manager for Optimmune said: "The results of our Early Diagnosis Programme made interesting reading and supported what we have always suspected - that KCS is under-diagnosed. It's really important that dogs suffering from this disease are detected promptly as early diagnosis and treatment with Optimmune gives the best prognosis.
"As part of the Early Diagnosis Programme owners of predisposed breeds received a personalised mailing offering them a free Schirmer Tear Test and some practices also elected to test all breeds at routine consultations such as vaccination. The tests were generally performed by veterinary nurses after they had received training, with the diagnosis made by a veterinary surgeon."
For more information about KCS, Optimmune and support in implementing an Early Diagnosis Programme, please contact your local Intervet / Schering-Plough Animal Health Territory Manager or call 01908 685685.
References¹ Pierce V & Williams D, 2006. Determination of Schirmer Tear Tests values in 1000 dogs. BSAVA Abstract 2006.² Intervet / Schering-Plough Animal Health Practices Study 2009
A wild golden eagle, one of only 442 breeding pairs, has died after being confiscated from a falconry expert who was nursing the animal back to health, and placed in the care of the RSPCA instead.
Roy Lupton, a falconer from Kent, saved the eagle in November last year, after it sustained injuries fighting a friend's bird. According to newspaper reports, Mr Lupton was given permission by the Scottish Executive to take the bird back to his premises in Kent to nurse it back to health. He planned to release the bird in the spring and claims he told Defra of his plans. Nevertheless, on May 5th, his premises were raided by Kent police, a Defra official and an official from the RSPB.
Despite his protests, the bird was seized and taken to the RSPCA's Mallydam wildlife centre in Sussex. Mr Lupton was questioned by police and the case passed to the Crown Prosecution Service. It was later dropped.
Meanwhile, Mr Lupton was allowed to visit the bird at the wildlife centre. He said: "I was horrified by what I saw. The RSPCA was keeping the bird on a concrete floor, which is bad for its talons, and there was leaf mould on the roof of the room, which can cause lung infections in golden eagles."
Mr Lupton was later allowed to take the animal home. However, its condition had deteriorated badly, and on June 17th he took the animal to see avian vet Neil Forbes. Sadly, nothing could be done, and the animal died hours later.
In his autopsy report, Neil said that the bird was kept in inappropriate conditions while in the care of the RSPCA and was "not provided with good practice in terms of husbandry". He added: "Whilst I cannot be certain the bird’s death was a direct result of the Defra seizure and the period of RSPCA care, certainly the stress effect (suppressing the immune system), the persistent systemic infection from the time of leaving the RSPCA care, does indicate a very high likelihood of a causative link between the period of care and the bird’s subsequent death."
Defra has been roundly criticised in the media today for reportedly spending £181,000 on redesigning its website.
Here's the old website. Apparently deemed 'too agricultural' for its use of brown.
And here's the new one:
A vast improvement, and depending on what the £181,000 bill included, it may not have been as overpriced as it sounds.
Either way, it prompted a great quip from Tory environment spokesman Nick Herbert: 'At least it's now clear that, like the rest of the country, Defra has gone off Brown.'
The new Aberdeen clinic will be based at Ardene House Veterinary Hospital, Kingswells in Aberdeen and will provide the out-of-hours cover for a number of veterinary practices in the Aberdeen area, treating their clients' pets at nights, weekends and bank holidays.
Vets Now was founded in 2001 when vet Richard Dixon, saw a gap in the market for not only providing an alternative to the 'on call' service which vets are required to provide by the Royal College of Veterinary Surgeons, but to providing a dedicated emergency service for pets, similar to A & E for humans. Vets Now now treats around 100,000 small animal emergencies every year with clinic teams working purely out-of-hours, to ensure that they are always fresh and ready to provide life saving treatment to pets who are injured or critically ill.
Richard said: "Vets Now has a clinic in Edinburgh and we have recently opened the first of our Vets Now Hospitals in Glasgow which combines emergency care with a range of specialist referral options, serving the whole of Scotland so we're looking forward hugely to extending our service in Scotland by bringing the dedicated emergency service to Aberdeen."
Vets Now will be working with Ardene House Veterinary Hospital, Abervet, Ashgrove Veterinary Centre, Bridge Veterinary Group and Swan Veterinary Practice to deliver their Out Of Hours emergency care.
Veterinary practices who would like to find out more about using the new Vets Now service in Aberdeen should contact Vets Now on 01383 620064.
The Prime Minister's website has received a petition for a new law making it compulsory to microchip pets in the UK.
If you wish to support this petition, please click here and add your name: http://petitions.number10.gov.uk/MicrochipPets/
The full petition reads:
"I am a responsible pet owner and have both my parrots and dog microchipped. I genuinely believe that all pets (where possible) should be microchipped.
I feel that it should be mandatory and is part of being a responsible pet owner. This should act as a "licence". I strongly beleive that this course of action will protect many discarded, stolen and mistreated pets every year as there will be no escape for the owners as the pet can be traced back to them.
I appreciated that due to size and temperament some pets may not be able to be microchipped, but certainly dogs, cats, horses, valuable / larger birds, rabbits etc should be.
I hope you agree that £30 for a microchip is good value, if owners cannot afford this then they shouldnt be considering a pet in the first place.
Please can you give this idea serious consideration as I feel we must do something to protect the pets that do not have a voice in our society."
As part of its Pet Factor campaign, the National Office of Animal Health has launched a competition via its consumer website Pet Health Information www.pethealthinfo.org.uk to find a pet with "the Pet Factor".
NOAH is inviting owners, vets, and vet nurses to go on to the website and put forward nominations, in no more than 200 words, of animals that have staged an amazing recovery, shown exceptional bravery or set themselves apart in some other way.
The Pet Factor campaign was launched with a set of three viral videos, focussing on Pet Factor auditions for a dog, cat, and hamster that reminded owners of the importance of basic pet care.
The PHI site encourages owners to go to talk to pet care professionals to seek advice about how to keep their pets healthy and happy.
Phil Sketchley chief executive of NOAH said: "The video campaign was very successful, with over 25,000 people having watched them so far. Now we want to take the campaign further and find pets that have done something special in a way that really embodies the spirit of 'the Pet Factor'."
The winning pet and their owner will receive a full photo shoot worth over £1,000 with renowned animal photographer Sam Lunt. The final photographs will be presented to them in a beautiful bound book, to remember their special day.
If you think one of your clients deserves to win, submit your 200 word entry at www.pethealthinfo.org.uk, with a photograph if you have one. The closing date is 28 February 2010.
To improve our understanding of the attitudes of vets to treating OA pain, a survey is being conducted in seven countries across Europe (Belgium, France, Germany, Italy, Netherlands, Spain and the UK) by a group of top European veterinarians.
The Pain Expert Panel intends to publish the results for each country and also the combined European results. These publications will allow comparisons to be made between countries and types of practices.
In addition, individual vets will be able to compare their own behaviours with the findings of the survey. It is hoped that the results will highlight any areas where continuing education would be beneficial and also topics for clinical research.
The survey is web based, completely anonymous and should take no more than 20 minutes to complete. Access details are as follows:
Website: www.painsurvey.net Password: pain
There is no right or wrong answer; your opinion is the only thing that matters.
The members of the European Expert Panel on Canine Osteoarthritis are: Dr. Bernard Bouvy (Fr), Prof. Stuart Carmichael (UK), Dr. Emilio Feltri (It), Prof. Jean-Pierre Genevois (Fr), Prof. Herman Hazewinkel (NI), Prof. John Innes (UK), Prof. Martin Kramer (Ge), Prof. Duncan Laschelles (USA), Dr. Carlos Macias (Sp), Dr. Sabine Tackle (Ge), Dr. Peter Vandekerckhove (Be)
Call for Research Reports / Research Abstracts 2010 ACVIM Forum Scientific Program SUMBISSION DEADLINE: DECEMBER 1, 2009 The ACVIM invites submission of research reports and research abstracts for short communications at the 2010 ACVIM Forum, June 9 - 12, 2010, in Anaheim, California. ACVIM Diplomates, ACVIM Candidates, members of other specialty groups, and those working in areas related to veterinary internal medicine are encouraged to submit. Research reports will be published in the online 2010 ACVIM Forum Proceedings and research abstracts will be published in the Journal of Veterinary Internal Medicine (JVIM) as well as in the online and CD-Rom 2010 ACVIM Forum Proceedings. Abstracts may be submitted for consideration in the research report category (25-minute presentation) if presented by an active researcher the field. PhD candidates, post-doctoral students, and young faculty may be considered, but ACVIM Candidates and other residents may not present in this category. If a research report is not accepted, the submission form will provide an option for you to have the abstract considered for presentation as a research abstract (15-minute presentation) instead. Anyone may submit abstracts to be considered in the research abstract category. ACVIM Candidates may be eligible for award. Awards will be given to selected research abstract presenters (or poster authors) who are active residents in an approved ACVIM training program, or who have completed an ACVIM approved residency within the last 6 months but are not yet ACVIM Board-certified. These abstracts will be judged on the quality of both the research and oral or poster presentation. Two types of research abstract communications will be available: - Oral presentation, strictly limited to 12 minutes with 3 additional minutes for questions. - Posters (4' × 8' in dimension), available for viewing throughout the meeting. During specified periods the posters must be attended by one or more of the authors to answer specific questions. If the poster is entered in the ACVIM resident competition, the author must attend the poster to interact with the judges. All submissions must adhere to the requirements outlined in the ACVIM Guidelines for Research Reports / Research Abstracts. Note: Abstracts that exceed the length limit will not be considered. Excessively poor grammar or clarity of writing may be grounds for abstract rejection. No abstract may be submitted that will have been submitted as a full-length publication before the abstract submission deadline of December 1, 2009. Abstracts that have been published as an abstract and / or presented elsewhere within the 9 months previous to the 2010 ACVIM Forum may be submitted for consideration, but must pass the ACVIM abstract review process as for any abstract. The place of prior publication and / or presentation and copyright permission must be disclosed at the time of abstract submission. Abstracts describing a single case report are unacceptable. Abstracts describing a study using clinical cases that lack confirmed, definitive diagnoses are not acceptable. Abstracts that present data “fractionated” into two or more abstracts when they could be combined into one are discouraged (e.g. regarding test validation, methodology development, or establishing a normal range without application to a population with sufficient power to demonstrate statistical significance). Animals used in the described study are expected to have received humane care, i.e. according to the principles outlined in the NIH Guide for the Care and Use of Laboratory Animals and / or the humane care guidelines found at the author’s institution. Authors must attest to this on the electronic submission form. Deadline: All submissions must be made online using the ACVIM electronic submission form found under the Research Abstracts link at www.ACVIMForum.org. Abstracts must be submitted by 11:59 pm MST, December 1, 2009 to be considered for presentation. The online submission form will be deactivated as of 12:00 am MST, December 2.
Nurtured Pets has launched the Anti-Lick Strip PreventTM, ProTM and Pro CTM, billed as an alternative to the clumsy and uncomfortable e-collar.
The Anti-Lick Strips deter animals from licking, biting or chewing of hot spots, granulomas and surgical sites. According to the company, they are also an effective deterrent to prevent such behaviours brought on by anxiety, boredom or even insect bites.
Hayley Booth, product manager at Nutured Pets said: "The UK pet market has been crying out for products like these for years. The unique bandages have medical grade adhesive on one side and all-natural active ingredients on the other. The combination of cayenne pepper, lemon powder, clove oil and oregano delivers a natural deterrent to the animal's nose and tongue to prevent it from interfering with the affected area.
"The Pro and Pro C are made exclusively for vets; the Pro can be used for direct application onto the pet's fur, ideal for securing IVs or catheters, the Pro C has a stronger adhesive and is ideal for over-wrapping gauze and cast materials.
"The Prevent then provides a profitable over the counter version for take home use. The preventative nature of these pet plasters may help promote healing and lessons the chance of infection, inflammation or re-opened wounds. In clinical trials, pets avoided the Anti-Lick Strip over 90% of the time proving these unique bandage strips really do work.
"The innovative features and benefits of the products themselves combined with extensive retail marketing support and highly visible point of sale display materials mean they're a must have for every vet practice."
For more information or a product sample, visit www.nurturedpets.co.uk or call 02476 302 222.
To celebrate the launch of its brand new keep reproduction simple advertisement campaign, CEVA Animal Health is giving British Cattle Veterinary Association (BCVA) Congress delegates the chance to win an iPod by entering a special spot the sperm competition.
BCVA Congress runs from 26-28 November 2009 in Southport. Delegates just need to spot five sperm lurking in the banner-sized cartoon for CEVA's GnRH product Ovarelin®. The correct answers will be entered into a draw to win an iPod.
The company says its new ad campaign brings together a series of cartoons with a clever play on words to highlight the importance of a simple protocol for success with reproduction. You can follow this irresistibull series in the farm media throughout the autumn.
For further information contact your local CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, www.ceva.uk.com
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
Urging vets to 'get off their backsides and respond to a VMD consultation' on the introduction of a new POM-EA category (Vet Times, 19th October) is premature.
Contrary to the report, the VMD has not yet launched a formal consultation.
Jo Cawthorne from the VMD said: "In fact, we've only launched an informal consultation on a concept note amongst a small group of key stakeholders from the RCVS, BVA, RPSGB, AMTRA, AHDA and NOAH, in order to decide whether this is a viable idea and merits a formal consultation."
She added: "There is no need for vets to respond to a consultation which doesn't yet exist. If there is a formal consultation, it will be announced formally on our website and everyone will be given the opportunity to respond."
A German Shepherd bitch is making an impressive recovery from serious burns, after treatment with manuka honey impregnated dressings.
'Lady' sustained her injuries after being trapped in a blazing house in Cornwall, as reported by the BBC. She has since been under the care of Amanda Manley at the Cornwall Animal Hospital, who has been using Activon Tulle Manuka honey impregnated dressings to treat the wounds.
Amanda said: "I'd like to say it was all down to the manuka honey, although it's difficult to make a scientific judgement without a control in place. Nevertheless I am very impressed with the results and will definitely use honey again in a similar situation"
Rachel Fuller, Product Manager for Activon (medical grade manuka honey dressings) at Dechra Veterinary Products said: "In human medicine, manuka honey has become popular as a result of its antibacterial and healing properties. All honey has a degree of effectiveness, but the unique properties of manuka honey make it by far the most effective for use on wounds. It is now gaining recognition among veterinary professionals, which has led to the introduction of honey-based wound management systems for animal care".
According to Dechra, Manuka honey has been shown to be effective against over 70 strains of bacteria commonly found in wounds, including MRSA1. It also has an osmotic effect which draws fluid from a wound bed and helps to remove slough and debride necrotic tissue that can harbour bacteria and impede wound healing2. It protects the wound bed and provides a moist wound healing environment3 and the water soluble antioxidants provide favourable conditions that help to promote granulation and epithelialisation, thus faster healing. There is a rapid reduction in odour when honey is applied to a malodorous wound and it also acts as an anti-inflammatory, which therefore reduces pain.
The Cornwall Animal Hospital is a registered charity which exists to provide affordable pet care to those on a low income. It has provided all Lady's treatment at cost, including the Activon dressings, which have since been replaced by Dechra as a gesture of support.
Photographs of the case at initial examination, post debridement / pre-treatment and post treatment are in the galleries.
References
Millpledge has launched Dermafuse Tissue Adhesive, an n-butyl cyanoacrylate medical adhesive used to bond tissue together following veterinary procedures.
Dermafuse contains a blue dye to help users see where product has been applied.
On contact with body tissue, Dermafuse changes from liquid to solid state by polymerizing within seconds to seal the wound.
Millpledge says the adhesive stops minor bleeding and binds wound edges, which may eliminate the need for sutures or bandages. In some instances it also acts as a barrier to keep foreign matter from entering the wound. The tissue adhesive is sloughed as healing occurs.
Each 3g bottle contains approximately 175 drops. Four sterile applicator tips are provided with each pack.
The RCVS is seeking candidates to run for election to the RCVS and VN Councils.
There are six seats on the RCVS Council and two on the VN Council due to be filled in the 2010 election. Candidate nominations must be received by 31 January 2010; voting papers will then be distributed to all veterinary surgeons and veterinary nurses eligible to vote, the election held in March and the results announced early in May. Those elected will take their seats at RCVS Day in July to serve four-year terms.
Jane Hern, RCVS Registrar said: "Like us or loathe us, what the RCVS does impacts directly on the lives of veterinary surgeons and nurses, their clients and patients. Getting regulation right is something that all Members and Listed/Registered VNs have power to influence.
"We know from the reaction we get when we propose changes or ask for your comments that vets and VNs are not backwards about coming forwards," Jane continued. "There has been a substantial rise in the number of vets voting, since a low point in voter turnout was reached in 2002. So, if you know someone you think is up to the job, why not persuade them to stand?"
All prospective candidates need to provide the signatures and registered/listed addresses of two proposers, and should also submit a short biography, 'manifesto' and photograph for inclusion in the elections booklets. Nobody can nominate more than one candidate, and no current member of the RCVS Council or VN Council may nominate anyone.
Newly elected RCVS Council members should expect to sit on at least one committee which, together with Council attendances, means a time commitment of at least six to eight days a year. Those elected to the VN Council should expect to spend approximately six to eight days attending Council meetings, working parties and subcommittees. Both RCVS Council and VN Council members are permitted to claim certain expenditures arising from Council-related duties and their employers can also claim a standard day-rate for loss of earnings.
Nomination forms and full details relating to RCVS Council nominations can be downloaded from www.rcvs.org.uk/rcvscouncil10 or obtained by contacting the Executive Office (020 7222 0761 or executiveoffice@rcvs.org.uk). Nomination forms and details relating to the VN Council will be online shortly at www.rcvs.org.uk/vncouncil10 and can also be requested from Annette Amato (020 7202 0788 or a.amato@rcvs.org.uk).
All nominations must be made in writing on the prescribed form and received by the Registrar on or before the closing date of 31 January 2010.
Protexin has announced that preliminary data from a clinical trial supports the use of Denamarin® to protect against lomustine (CCNU)-induced hepatotoxicity in dogs.
The study is being performed at the University of California-Davis, Veterinary Medical Teaching Hospital, and the initial results were recently presented at the American College of Veterinary Internal Medicine (ACVIM) Annual Forum. Marketed in the UK by Protexin, Denamarin is the combination of S-adenosylmethionine (SAMe) and silybin.
According to the company, most dogs treated with the chemotherapeutic agent CCNU experience liver enzyme elevation. Elevation of certain liver enzymes such as alanine transferase (ALT) is a key indicator of liver trauma; significant enzyme elevation may lead to a discontinuation, delay, or reduction in chemotherapy. The ongoing clinical trial was designed to evaluate Denamarin as a hepatoprotectant in dogs diagnosed with neoplasia that are undergoing CCNU therapy.
The trial consists of two groups of randomly assigned dogs. Dogs in Group 1 receive Denamarin beginning at the start of CCNU therapy. Group 2 dogs do not receive Denamarin unless they develop a Grade IV hepatotoxicity.
Results of a planned interim analysis completed on the first 30 dogs enrolled revealed that starting Denamarin when CCNU therapy was instituted (Group 1 dogs) appeared to provide hepatoprotection. While the mean post-therapy ALT elevation for Group 1 was 119 IU/L (p=0.1), for Group 2 dogs, the post-therapy ALT level was 815 IU/L (p=0.046). Chemotherapy was altered due to elevated liver enzymes in three Group 2 dogs but only one dog in Group 1.
Janine Barlow, Technical Manager at Protexin said: "We are extremely pleased by the initial findings of this research. The use of Denamarin with chemotherapy looks to help protect liver function allowing for successful completion of therapy and hopefully a longer, happier life for the pet. We look forward to the results of the full study."
Protexin says the SAMe and silybin in Denamarin support and maintain hepatic function by mechanisms including increasing levels of glutathione, the liver's main detoxifying agent; promoting protein synthesis; and stimulating bile flow. Denamarin is useful as part of a polymodal approach to the management of liver health.
Denamarin is available for both dogs and cats in an enteric-coated tablet.
A new equine parasite supplement to the online peer-reviewed publication Parasites and Vectors has been published by Fort Dodge.
Entitled "Equine parasites: diagnosis and control - a current perspective," it contains papers on a range of topics including a major European resistance study into key anthelmintic molecules. It is authored by equine parasitology experts and opinion leaders from around the world and was first published in September 2009. It is freely available at http://www.parasitesandvectors.com/
The Small Animal Medicine Society is pleased to announce the launch of the SAMSOC Travel Scholarship
The scholarship, worth £250, can be awarded to any SAMSOC member undertaking CPD to study a particular aspect of Small Animal Medicine.
Applicants should describe how they would use the award in 300-400 words and are free to choose the topic to be studied. Recipients of the award are required to undertake the CPD within the subsequent 12 months.
Following completion of their trip the winner is required to write a summary article (approx 1000 words) which will be submitted to the Veterinary press for publication and placed on the SAMSOC website.
The award is only open to SAMSOC members.
Applications should be sent to the Ian Battersby ( iab@vetspecialists.co.uk ) to arrive no later than 31st December 2009, the successful applicant will be notified within 6 weeks. The award will be presented at the SAMSOC Meeting on 7th April 2010.
The National Office of Animal Health (NOAH) has launched a new 'Use Medicines Responsibly' campaign.
The main thrust of the campaign is an initiative by NOAH to encourage pharmaceutical companies to add: 'Use Medicines Responsibly' as a strapline to their own advertising campaigns, with a link to the NOAH information resource for prescribers and users of animal medicines: www.noah.co.uk/responsible.
Speaking at the NOAH annual members' conference in Northampton, NOAH chief executive Phil Sketchley said: "NOAH believes responsible promotion of animal medicines to be an important link in the chain towards responsible use. Companies' promotional material can educate prescribers and users of animal medicines to the benefit of their animals' health and welfare.
"We believe this new advice resource, with the reminder on advertisements, will help."
Genitrix has repackaged its Dentagen plaque prevention chews to provide added value and convenience to pet owners.
Packs of the chews, launched in 2008 as part of Genitrix' Dentagen dental range, will now be available in 'one month' packs in response to customer feedback. The new, bigger value packs will also be priced more cost-effectively and will offer environmental benefits as the amount of packaging is reduced.
Dentagen dental chews are impregnated with a plant extract called RF2 which enables them to act as an 'anti-biofilm' treatment, modifying the membrane of oral bacteria to prevent them from producing plaque. The chews, which come in two sizes for large and small dogs, are designed to be given on alternate days and form part of the unique Dentagen Dental Care Programme. Earlier this year, Genitrix also launched Dentagen Aqua, an innovative water additive treatment to control plaque and prevent bad breath in cats and dogs.
The new size packs of Dentagen chews, which will be available exclusively through veterinary channels, cost £6.35 for a pack of 14 small chews (one month's supply) and £8.09 for 14 large chews.